Malaria Prevention for Long-Term Travelers and Expats: When Daily Pills Stop Being the Whole Plan

Malaria prevention for a two-week vacation and malaria prevention for a two-year posting are not the same problem. The CDC's own guidance for long-term travelers and expatriates flags the real risk directly: adherence to daily or weekly antimalarials declines the longer someone stays, and in one cited workplace study, every employee stationed on-site for more than a year had stopped taking prophylaxis entirely. A separate long-term safety study followed 169 travelers and expatriates through more than 2,974 weeks of atovaquone-proguanil (Malarone) use and found it well tolerated well beyond the 28-day window most people associate with it. In our clinical experience, the travelers who get malaria after living abroad for months are rarely the ones who never took precautions. They are the ones who started strong and quietly stopped. Start your visit on Wandr to talk through a prevention plan built for your actual length of stay, not just your flight dates.

Why Long-Term Travelers Are a Different Risk Category

Short-term prophylaxis is a solved problem: take Malarone starting a day or two before you arrive, take it daily while you're there, finish the 7-day course after you leave. Long-term travel breaks that simplicity in a specific way. The CDC Yellow Book's chapter on long-term travelers and expatriates states plainly that "even when urged to adhere to personal protective measures and reassured that long-term prophylaxis is safe and effective, traveler adherence likely will decline over time." That is not a judgment on discipline. It is what happens when a preventive habit stops feeling connected to an obvious, present risk.

The same CDC guidance cites a striking data point: among British expatriates in one study, adherence to malaria prophylaxis fell below 25% over time. Another cited workplace cohort found that every employee who had been on-site for more than a year had abandoned prophylaxis altogether. Malaria risk does not fall off in the same way. In much of sub-Saharan Africa, transmission is year-round, and the WHO African Region still accounts for roughly 94% of global malaria cases and 95% of malaria deaths, according to the WHO World Malaria Report 2025.

What the Data Actually Says About Extended Malarone Use

A lot of long-term travelers assume Malarone simply is not built for extended stays because the FDA label references a 28-day travel window. The clinical safety data tells a more complete story. A published long-term surveillance study followed 169 non-immune travelers and expatriates through 2,974 person-weeks of atovaquone-proguanil use, more than 57 person-years combined. Just under half (44.4%) reported no side effects at all. Among those who did, the most common complaint was mild to moderate diarrhea, and only 2.4% of participants discontinued the medication because of side effects. No one in the study was hospitalized. The study's own conclusion: atovaquone-proguanil "was tolerated well when taken longer than the current recommendation of 28 days of travel," supporting its use as a safe option for long-term chemoprophylaxis against falciparum malaria.

That does not mean daily Malarone is automatically the right call for every multi-year stay, and it is not a substitute for an individual review. Cost adds up over months of daily dosing, and our providers weigh that against your specific destination, itinerary, and health history. It does mean that "I'm here too long for pills to make sense" is not a conclusion you should reach on your own. This is something we discuss during your Wandr visit, and our providers can tell you whether continuing daily Malarone, adjusting your refill schedule, or revisiting the plan at set intervals fits your situation.

Where Other Antimalarials Fit In (and Where They Don't)

For context, and only for context, it's worth knowing what else exists in this space, since you may see these names in expat forums or from a local clinic abroad. Doxycycline has no CDC-defined duration limit for malaria prophylaxis and has been well tolerated in long-term military use, which is part of why it comes up often in long-stay discussions. Mefloquine offers convenient weekly dosing for extended trips, but it carries an FDA boxed warning because its neuropsychiatric side effects can persist even after the medication is stopped. Wandr does not prescribe doxycycline or mefloquine. We prescribe atovaquone-proguanil (Malarone) because of its favorable side-effect profile and the safety data above, and our providers can walk you through how that fits a long-term stay specifically.

Practical Planning for Months, Not Weeks

Arrange your supply before you leave. Filling a 2- to 3-month supply through a US pharmacy before departure, with a plan for scheduled refills through Wandr, is simpler than trying to source and verify the same medication once you're abroad, where availability, labeling, and pharmacy practices vary widely by country.

Set a recurring reminder, not a one-time one. The CDC's core adherence problem for long stays is that daily pill-taking eventually blends into the background. A recurring phone alarm tied to something you already do daily (breakfast, brushing your teeth) outlasts a habit built on willpower alone.

Re-check in at defined intervals, not just at the start. A health profile that was accurate on day one of a two-year posting may not be accurate at month fourteen. Our providers can build a check-in into your visit schedule so your prevention plan gets revisited, not just prescribed once and forgotten.

Keep bite prevention as your first line, always. The CDC lists insect bite avoidance, insecticide-treated bed nets, and screened or air-conditioned rooms as the foundation of malaria prevention, with medication as the second layer. That ordering matters more, not less, over a long stay, since no antimalarial is 100% effective on its own.

Frequently Asked Questions

How long can I safely take Malarone (atovaquone-proguanil)? A published long-term study followed travelers and expatriates through more than 57 person-years of atovaquone-proguanil use and found it well tolerated beyond the 28-day window referenced on the label, with a discontinuation rate for side effects of only 2.4%. Our providers can review whether continued use makes sense for your specific stay length and health history.

Why do so many expats stop taking malaria pills after a few months? The CDC attributes this to declining adherence over time, not a change in actual risk. One cited study found British expatriate adherence fell below 25% over time, and another found every employee on-site for more than a year had stopped prophylaxis entirely, even though malaria transmission in most endemic regions is year-round.

What's the alternative to daily pills for someone living in a malaria zone long-term? Insect bite prevention (repellent, treated bed nets, screened housing) is the foundation regardless of medication choice. On the medication side, Wandr prescribes atovaquone-proguanil for eligible long-term travelers; other options exist in the broader medical literature, and our providers can discuss what fits your specific circumstances during your visit.

Can I get a larger supply of Malarone before I leave the US? This is something our providers evaluate case by case based on your itinerary and length of stay. Start your Wandr visit to discuss a supply and refill plan that matches your trip.

Does insect repellent and a bed net really make a difference if I miss a dose here and there? Yes. The CDC frames personal protective measures as the primary defense and medication as a second layer, precisely because no antimalarial is 100% effective and because real-world adherence to any daily regimen is imperfect over long stays. Reliable bite prevention lowers your risk regardless of how consistently you take medication.

Should I switch medications for a multi-year stay? That depends on your individual health profile, budget, and how the trip itself is structured, and it is not a decision to make from a forum post. Our providers can review your history and discuss whether your current plan still fits as your stay goes on.

Sources

1. Centers for Disease Control and Prevention. Long-Term Travelers and Expatriates. CDC Yellow Book. https://www.cdc.gov/yellow-book/hcp/travel-for-work-other/long-term-travelers-and-expatriates.html
2. Schlagenhauf P, et al. "The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of Plasmodium falciparum malaria in non-immune travelers and expatriates." American Journal of Tropical Medicine and Hygiene (via PubMed). https://pubmed.ncbi.nlm.nih.gov/17367478/
3. World Health Organization. World Malaria Report 2025. WHO Global Malaria Programme. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025
4. Centers for Disease Control and Prevention. Malaria. CDC Yellow Book, 2026 Edition. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/malaria.html
5. Centers for Disease Control and Prevention. Choosing a Drug to Prevent Malaria. https://www.cdc.gov/malaria/hcp/drug-malaria/index.html

Related Reading

For the full decision framework on malaria medication, see our malaria prevention complete guide. For dosing specifics, see Malarone dosage and side effects and when to start and stop Malarone.

Medical Disclaimer

This article is for general educational purposes and does not replace individualized medical advice. Malaria prevention needs vary by destination, length of stay, and individual health history. Our providers review your health profile before prescribing anything.

Start your visit on Wandr and get a malaria prevention plan built for your actual trip length (see /destination-check)